-
EP2205584
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2205584
| EP2205584 - SPIROPYRROLIDINES AND THEIR USE AGAINST HCV AND HIV INFECTION [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 04.03.2016 Database last updated on 22.08.2024 | Most recent event Tooltip | 04.03.2016 | Application deemed to be withdrawn | published on 06.04.2016 [2016/14] | Applicant(s) | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | [2010/28] | Inventor(s) | 01 /
BRITT, Shawn, D. 56 Marilyn Road Andover Massachusetts 01810 / US | 02 /
CISZEWSKI, Lech, Andrzej 7 Hamilton Road (Apt. 2h) Morristown New Jersey 07960 / US | 03 /
FU, Jiping 74 Cutter Hill Road Arlington, Massachusetts 02474 / US | 04 /
KARUR, Subramanian 9 Ryder Street Apt. 20 Arlington Massachusetts 02476 / US | 05 /
LIU, Yugang 57 Huntley Way Bridgewater NJ 08807 / US | 06 /
PARKER, David Thomas 541 Bedford Street Lexington Massachusetts 02420 / US | 07 /
PRASHAD, Mahavir 27 Davenport Road Montville New Jersey 07045 / US | 08 /
RAMAN, Prakash 125 Summer Street Acton Massachusetts 01720 / US | 09 /
SEEPERSAUD, Mohindra 9 Highland Road Acton Massachusetts 01720 / US | 10 /
ZHENG, Rui 1008 Stearns Hill Road Waltham Massachusetts 02451 / US | 11 /
LU, Peichao 36 Dartmouth Street Apt. 410 Malden Massachusetts 02148 / US | 12 /
RIGOLLIER, Pascal 4 bis Avenue de la Première Division Blindée F-68100 Mulhouse / FR | 13 /
YIFRU, Aregahegn 14 Murdock Street Apartment 2-7 Somerville, Massachusetts 02145 / US | [2010/28] | Representative(s) | Strang, Andrea Josephine, et al Novartis Pharma AG Patent Department Postfach 4002 Basel / CH | [N/P] |
| Former [2010/28] | Strang, Andrea Josephine, et al Novartis Pharma AG Patent Department Postfach 4002 Basel / CH | Application number, filing date | 08805142.0 | 08.10.2008 | [2010/28] | WO2008EP63460 | Priority number, date | US20070978974P | 10.10.2007 Original published format: US 978974 P | [2010/28] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2009047264 | Date: | 16.04.2009 | Language: | EN | [2009/16] | Type: | A1 Application with search report | No.: | EP2205584 | Date: | 14.07.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.04.2009 takes the place of the publication of the European patent application. | [2010/28] | Search report(s) | International search report - published on: | EP | 16.04.2009 | Classification | IPC: | C07D401/12, C07D403/12, A61K31/403, A61K31/44, A61K31/497, A61P31/12 | [2010/28] | CPC: |
C07D401/12 (EP,CN,KR,US);
C07D403/12 (EP,CN,KR,US);
A61K31/4025 (KR);
A61P1/16 (EP);
A61P31/00 (EP);
A61P31/12 (EP);
A61P31/14 (EP);
A61P31/18 (EP);
A61P43/00 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/28] | Extension states | AL | 10.05.2010 | BA | 10.05.2010 | RS | 10.05.2010 | Title | German: | SPIROPYRROLIDINE UND IHRE VERWENDUNG GEGEN HCV- UND HIV-INFEKTIONEN | [2010/28] | English: | SPIROPYRROLIDINES AND THEIR USE AGAINST HCV AND HIV INFECTION | [2010/28] | French: | SPIROPYRROLIDINES ET LEUR UTILISATION CONTRE L'INFECTION HCV ET HIV | [2010/28] | Entry into regional phase | 10.05.2010 | National basic fee paid | 10.05.2010 | Designation fee(s) paid | 10.05.2010 | Examination fee paid | Examination procedure | 10.05.2010 | Examination requested [2010/28] | 29.06.2010 | Amendment by applicant (claims and/or description) | 16.06.2015 | Despatch of a communication from the examining division (Time limit: M04) | 27.10.2015 | Application deemed to be withdrawn, date of legal effect [2016/14] | 27.11.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2016/14] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 16.06.2015 | Fees paid | Renewal fee | 12.10.2010 | Renewal fee patent year 03 | 11.10.2011 | Renewal fee patent year 04 | 11.10.2012 | Renewal fee patent year 05 | 14.10.2013 | Renewal fee patent year 06 | 14.10.2014 | Renewal fee patent year 07 | Penalty fee | Additional fee for renewal fee | 31.10.2015 | 08 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2005058821 (SCHERING CORP [US], et al) [A] 1-34 * Formula (I),; page 9, line 16 - page 10, line 6; claims 1,16,21 * * page 12, line 17, paragraphs 12,13,114 - page 13, line 7 *; | [PX]WO2007120595 (NOVARTIS AG [CH], et al) [PX] 1-34 * page 2, lines 9-19 - line 17 * * page 12, lines 4-17 * | [A] - SAVINA MALANCONA, STEFANIA COLARUSSO, JESUS M. ONTORIA, ANTONELLA MARCHETTI ET AL., "SAR and pharmakinetic studies on phenethylamide inhibitors of the hepatitis C virus NS3/NS4A serine protease", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (2004), vol. 14, pages 4575 - 4579, XP002511585 [A] 1-34 * table 2 * DOI: http://dx.doi.org/10.1016/J.BMCL.2004.05.093 | [A] - DE FRANCESCO ET AL, "Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER BV, AMSTERDAM, NL, (20070811), vol. 59, no. 12, ISSN 0169-409X, pages 1242 - 1262, XP022328021 [A] 1-34 * figure 2 * DOI: http://dx.doi.org/10.1016/j.addr.2007.04.016 |